Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation.

Autor: McIlroy, Graham1 (AUTHOR), Nikolousis, Emmanouil1 (AUTHOR), Abou-Zeid, Nervana1 (AUTHOR), Shankara, Paneesha1 (AUTHOR), Kishore, Bhuvan1 (AUTHOR), Kaparou, Maria1 (AUTHOR), Lovell, Richard1 (AUTHOR), Elmoamly, Shereef1,2 (AUTHOR), Davies, David1 (AUTHOR), Horgan, Claire1 (AUTHOR), Shenouda, Amir1 (AUTHOR), Kanellopoulos, Alexandros1 (AUTHOR) akanell@hotmail.com
Zdroj: Leukemia & Lymphoma. Jan2020, Vol. 61 Issue 1, p202-205. 4p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje